Marlene Balys

1.7k citations
28 papers · 1.1k indexed · 1 hit paper · h-index 13
Topics
Acute Myeloid Leukemia Research (13 papers)Protein Degradation and Inhibitors (6 papers)Glycosylation and Glycoproteins Research (4 papers)
Partner nations
United StatesFranceIndia

In The Last Decade

Marlene Balys

26 papers receiving 1.1k citations

Hit Papers

Leukemic Stem Cells Evade Chemotherapy by Metabolic Adapt...20162026201920222016100200300

Peers

Marlene Balys
Comparison fields: 5 of 82
  • Molecular Biology 775
  • Immunology 263
  • Hematology 259
  • Cancer Research 230
  • Organic Chemistry 199
Replace Mitchell B. Diccianni with:
Mitchell B. Diccianni United States
June Escara‐Wilke United States
Beatriz Albella Spain
Kim R. Kampen Netherlands
Nerea Allende-Vega France
Jeffrey D. Bray United States
Bibiana I. Ferreira Portugal
Subbulakshmi Virudachalam United States
R A Rifkind United States
Jaira F. de Vasconcellos United States
Marlene Balys relative to Mitchell B. Diccianni United States Mitchell B. Diccianni's profile →
Citations per field
00.5×6.6×
Mitchell B. Diccianni · 1×
Citations per year

Countries citing papers authored by Marlene Balys

Since Specialization
Citations

This map shows the geographic impact of Marlene Balys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlene Balys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlene Balys more than expected).

Fields of papers citing papers by Marlene Balys

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlene Balys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlene Balys. The network helps show where Marlene Balys may publish in the future.

Co-authorship network of co-authors of Marlene Balys

This figure shows the co-authorship network connecting the top 25 collaborators of Marlene Balys. A scholar is included among the top collaborators of Marlene Balys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlene Balys. Marlene Balys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 8
3
Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Nichebreakdown →
395
4 1
5 1
6 1
7 45
8 31
9 45
10 43
11 1
12 1
13 61
14 45
15 19
16 89
17 31
18 93
19 110
20 95

About Marlene Balys

Marlene Balys is a scholar working on Hematology, Cancer Research and Genetics, having authored 28 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (13 papers), Protein Degradation and Inhibitors (6 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Hematology (259 citations), Cancer Research (230 citations) and Immunology (263 citations). Marlene Balys has collaborated with scholars based in United States, France and India. Frequent co-authors include Kelly G. Ten Hagen, Lawrence A. Tabak, Thomas M. Beres, Fred K. Hagen, Craig T. Jordan, Mohammad Minhajuddin, John M. Ashton, Brett M. Stevens, Haobin Ye and Shanshan Pei. Their work appears in journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026